Lithuanian watchdog might appeal quashed fines for collusion on drug margins
( June 18, 2025, 09:14 GMT | Official Statement) -- MLex Summary: Lithuania’s antitrust enforcer has said it is considering appealing a court ruling that annulled its 2022 decision to fine the Lithuanian Pharmacy Association and eight pharmaceutical companies more than 72 million euros for agreeing on margins for reimbursable drugs. In the court’s view, the conduct didn’t breach antitrust rules. The authority will assess the court’s arguments and consider the possibility of appealing the verdict.Statement follows (in Lithuanian). ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.